Omidria® receives positive opinion from European Medicines Agency's CHMP
Omeros announced the EMA's Committee for Medicinal Products for Human Use has adopted a positive opinion for Omidria® (phenylephrine and ketorolac injection) 1%/0.3%. Omidria is used during cataract surgery and other intraocular lens replacement procedures. May 22, 2015